Admission Date:  [**2179-11-18**]              Discharge Date:   [**2179-11-27**]  Date of Birth:  [**2100-1-11**]             Sex:   F  Service: MEDICINE  Allergies: Sulfa (Sulfonamide Antibiotics)  Attending:[**First Name3 (LF) 2009**] Chief Complaint: Pulmonary Embolism Intergluteal Hematoma Intracranial Hemorrhage  Major Surgical or Invasive Procedure: Inferior Vena Cava Filter Placement   History of Present Illness: Ms. [**Known lastname 41033**] is a 79 year-old woman transferred from the [**Hospital 882**] hospital emergency department.
She was recently living at rehab after a prior hospitalization at [**Hospital1 882**] starting [**11-8**].
At that time she sufferred intraventricular hemorrhage and interglutteal hemorrhage in her R iliacus muscle, leading to Hct drop requiring 4 units pRBC and ICU level care.
There she was found to have extensive bilateral pulmonary emboli with RV dilatation (RV:LV ratio 2:1) as well as evidence of apiration.
She received levofloxacin and CTX.
She is on NC 4-6L now.
She was not heparinized due to recent bleed VS currently:  98, 113/72, 20, 96.3, 95% on 5 L NC   Past Medical History: Dementia/ Alzheimer's Disease Hypothyroidism Sensory Motor Neuropathy Unsteady Gait s/p multiple falls Joint pain/Arthropathy Colitis OSA   Social History: She lived with her husband and was independent in ADLs prior to transfer to rehab after her recent hospitalization.
Family History: Noncontributory  Physical Exam: VS: T 98, HR 92, RR 17, BP 125/61, O2 95% on 5L GEN: crabby, reluctant to accept exam, appropriately conversational but only oriented x 2 (person, [**2179**]) HEENT: PERRL, mucosa moist RESP: clear bilaterally CV: RV heave, prominent neck vein pulses, no murmurs ABD: soft, nontender, pelvic ecchymoses extending around R flank and into buttocks EXT: trace bilateral pitting edema SKIN: ecchymoses on pelvic, flank, buttocks NEURO: oriented x 2, PERRL, CN 2-12 intact RECTAL:  deferred   Pertinent Results: [**2179-11-18**] 01:13AM   PH-7.34* COMMENTS-GREEN TOP [**2179-11-18**] 01:13AM   GLUCOSE-170* LACTATE-2.7* NA+-138 K+-4.3 CL--100 TCO2-27 [**2179-11-18**] 01:13AM   freeCa-1.18 [**2179-11-18**] 01:10AM URINE  BLOOD-SM NITRITE-NEG PROTEIN-75 GLUCOSE-NEG KETONE-NEG BILIRUBIN-SM UROBILNGN-1 PH-6.5 LEUK-TR [**2179-11-18**] 01:10AM URINE  RBC-[**6-24**]* WBC-[**3-19**] BACTERIA-FEW YEAST-NONE EPI-0-2 [**2179-11-18**] 01:05AM   cTropnT-0.15* [**2179-11-18**] 01:05AM   WBC-15.6* RBC-3.54* HGB-10.9* HCT-32.8* MCV-93 MCH-30.7 MCHC-33.2 RDW-15.3 [**2179-11-18**] 01:05AM   NEUTS-94.3* LYMPHS-2.1* MONOS-3.4 EOS-0.1 BASOS-0.1 [**2179-11-18**] 01:05AM   PLT COUNT-255 [**2179-11-18**] 01:05AM   PT-13.7* PTT-23.0 INR(PT)-1.2* .
Thrombus in the left deep femoral vein at junction with superficial femoral vein, extending proximally in the common femoral vein for approximately 1 cm.
Thrombus in one of the peroneal veins in the right calf.
She was hemodynamically stable on admission and required 5L oxygen via NC to keep oxygen saturation above 93%.
To protect her lungs from further embolic trauma, an IVC filter was placed.
Cardilogy was consulted and determined that catheter-based embolectomy was not indicated.
Neurosurgery was alos consulted and determined that anticoagulation would be safe, however anticoagulation was withheld  started due to concern for further intramuscular bleeding.
It was determined that her intragluteal bleed was stable and anticoagulation was initiated with weight based IV heparin without bolus on hospital day 3 ([**11-20**].)
She was therapeutic on heparin IV and was started on Coumadin on hospital day 4.
She was maintained therapeutic on IV heparin until her Coumadin was therapeutic for greather than 24 hours and then IV heparin was discontinued on hospital day 8.
She remained therapeutic on Coumadin for the remained for her admission.
She was also evaluated by phsical therapy and it was determined that she would benefit for physical rehabilitation after discharge.
# Intracranial hemorrhage: She was evaluated by neurosurgery and determined to be stable for anticoagulation from a neurosurgical standpoint.
Her namenda and donepazil were continued.
She seldom became agitated in the evening and responded well to re-orientation in these circumstanses.
She rarely required 2.5 mg of olanzapine for agitation that was not responsive to re-orientation.
# Colitis: Sulfasalazine was continued.
# Hypothyroidism:  Levothyroxine was continued.
# Communication: HCP is [**Name (NI) 4906**] [**Telephone/Fax (1) 77504**], Cell [**Telephone/Fax (1) 77505**], Patient and daughters - [**Name (NI) **] [**Telephone/Fax (1) 77506**] ([**Name2 (NI) 4565**]), daughter [**Name (NI) 698**] [**Telephone/Fax (1) 77507**] [**Name2 (NI) 3914**], and daughter [**Name (NI) 402**] [**Telephone/Fax (1) 77508**]   Medications on Admission: Neurontin 100 [**Hospital1 **] Aricept 5 mg daily Namenda 5 daily Levoxyl 25 mcg daily Omeprazole 20 daily Calcium /Vitamin D 600/400 mg [**Hospital1 **] Sulfasalazine 500 TID   Discharge Medications: 1. gabapentin 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
2. donepezil 5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime).
3. memantine 5 mg Tablet Sig: One (1) Tablet PO daily ().
4. levothyroxine 25 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
5. omeprazole 20 mg Capsule, Delayed Release(E.C.)
6. sulfasalazine 500 mg Tablet Sig: One (1) Tablet PO TID (3 times a day).
8. warfarin 1 mg Tablet Sig: Three (3) Tablet PO Once Daily at 4 PM: Please check INR tomorrow [**2179-11-28**].
Patient will be continued on Warfarin for at least 3 months please verify with PCP to [**Name9 (PRE) 77509**] appropriate STOP date.
When you arived, you could not receive blood thinning medication because of your head and back bleeds; instead you received a vein filter to protect your lungs form further clots.
After further studies, your head and back bleeds were determined to be stable with the help of the Neurosurgery and General Surgery service.
Your blood clots were treated with the appropriate medications and your breathing improved.
You were STARTED on Coumadin 3mg daily, this medication need monitoring and adjustment at least every three days until your dose is stable.
Please take your medications as prescribed and keep your outpatient appointments.
